Brian David Smith: Difference between revisions
The birth year appears to have been vandalism |
Wickie Bruce (talk | contribs) m this update reflects some changes in Prof Smith's university accreditation and adds selected research and other publications. |
||
| Line 1: | Line 1: | ||
'''Brian David Smith''' PhD, BSc (Hons), FCIM, is |
'''Brian David Smith''' PhD, BSc (Hons), FCIM, is an academic researcher and author in the area of strategic management, with a particular interest in the evolution of business models and competitive strategies in the life science sector, especially pharmaceuticals and medical technology.In addition to his research and writing, he also advises a range of companies in this industry. |
||
==Early life and education== |
==Early life and education== |
||
Brian David Smith was born in [[Hebburn]] in 1961. Smith's first degree was in Chemistry from [[Newcastle University]] (1983). He then spent 5 years working as a research chemist and a further 15 years in marketing management with large pharmaceutical and medical technology companies. He became a qualified marketer in 1989 and served as the first non-academic examiner for the Chartered Institute of Marketing. In 2003, he gained his PhD from Cranfield School of Management. His thesis, supervised by Professor Malcolm McDonald, was entitled ''The Effectiveness of Strategy Making Processes in Medical Markets''. |
Brian David Smith was born in [[Hebburn]] in 1961. Smith's first degree was in Chemistry from [[Newcastle University]] (1983). He then spent 5 years working as a research chemist and a further 15 years in marketing management with large pharmaceutical and medical technology companies. He became a qualified marketer in 1989 and served as the first non-academic examiner for the Chartered Institute of Marketing. For almost 30 years, he was heavily involved in the CIM, especially as chair of its Levitt Group for senior and qualified marketers. In 2003, he gained his PhD from Cranfield School of Management. His thesis, supervised by Professor Malcolm McDonald, was entitled ''The Effectiveness of Strategy Making Processes in Medical Markets''. |
||
==Academic career== |
==Academic career== |
||
He is an adjunct Professor at Bocconi University in Milan, Italy, where he teaches Strategy and Organisational Behaviour on the [http://www.sdabocconi.it/en/specialized-master-full-time-executive/mihmep MIHMEP] programme and does research in the [http://www.cergas.unibocconi.it/wps/wcm/connect/Cdr/Centro_CERGASit/Home CERGAS] research centre. He is also a Visiting Professor at the [http://www.herts.ac.uk/ University of Hertfordshire], where he supervises a group of PhD students focused on the evolution of the life sciences industry. |
|||
He is Visiting Research Fellow in the Marketing and Strategy Research Unit of the [[Open University]] Business School,<ref>http://www.open.ac.uk/oubs/people-and-partners/people-profile.php?staff_id=2814</ref> Europe's largest business school, and was formerly a researcher at the [[Cranfield University]] School of Management. |
|||
As an author, he has written more than |
As an author, he has written more than 300 papers, articles and books. These include five major books.<ref>http://www.pragmedic.com/what-weve-written</ref>. These include [https://www.amazon.co.uk/Darwins-Medicine-Business-Sciences-Industry-ebook/dp/B01MDMG0JQ Darwin's Medicine] and [https://www.amazon.co.uk/Future-Pharma-Brian-D-Smith-ebook/dp/B007BDJSQG/ref=sr_1_1?s=digital-text&ie=UTF8&qid=1499424898&sr=1-1&keywords=The+future+of+pharma The Future of Pharma], which are perhaps his best known works. Smith was also the editor of the Journal of Medical Marketing, a peer-reviewed journal.<ref>http://www.palgrave-journals.com/jmm/index.html</ref> |
||
As an advisor, he works mostly in the pharmaceutical |
As an advisor, he works mostly in the pharmaceutical, medical technology and related sectors, in which he has spent his management career. He has worked with most of the major companies and many smaller ones in this industry. |
||
He is heavily involved in the [[Chartered Institute of Marketing]]. A former International Vice Chair, he became a Fellow of the CIM in 1999. He now chairs the CIM's Levitt Group<ref>{{cite web|url=http://www.cim.co.uk/events/MIGs/mrktnetwork.aspx |title=Archived copy |accessdate=2010-01-13 |deadurl=yes |archiveurl=https://web.archive.org/web/20100107222317/http://www.cim.co.uk:80/events/MIGs/mrktnetwork.aspx |archivedate=2010-01-07 |df= }}</ref> and serves on the committee of the Medical Marketing Group.<ref>{{cite web|url=http://www.cim.co.uk/events/MIGs/cimmmg.aspx |title=Archived copy |accessdate=2010-01-13 |deadurl=yes |archiveurl=https://web.archive.org/web/20100107233245/http://www.cim.co.uk:80/events/MIGs/cimmmg.aspx |archivedate=2010-01-07 |df= }}</ref> |
|||
==Research== |
==Research== |
||
=== Current research === |
=== Current research === |
||
Smith's current research focus is on |
Smith's current research focus is on the application of Darwinian Evolution to understand the evolution of business models in the life sciences industry. His work builds on his prior research streams concerning the effectiveness of strategy making in life science companies, how firms create market insight and the connection between strategy and commercial outcomes. His peer-reviewed research publications include: |
||
===Research foundation=== |
|||
Smith's research brings together various streams of previous research by others in the field. |
|||
* Research by [[Henry Mintzberg]] and others into the hybrid processes (planning, vision, [[incrementalism]]) that firms use to create strategy. |
|||
* Research into how different processes fit with different levels of market complexity and turbulence. |
|||
* Research into how internal factors such as company culture help or hinder strategic planning. |
|||
* Burrell and Morgan's ''congruency hypothesis''. |
|||
===Research contributions=== |
|||
Contributions made by Smith to this field of research include: |
|||
* The ''What Works is What Fits'' conclusion, leading to Smith's recommendation that companies should not copy so-called 'best practice', but instead craft hybrid strategy making processes that fit their unique combination of market conditions and organisational culture. This research is covered in Smith's first book, ''Making Marketing Happen''. |
|||
* Clarification of what 'strong strategy' looks like and how it differs from weak strategy. Smith's work develops a series of tests for the resource allocation choices made by firms and relates them to whether the strategy will destroy or create shareholder value. This work is explained in Smith's second book, co-written with Professor Malcolm McDonald and Professor Keith Ward, ''Marketing Due Diligence''. |
|||
• Smith BD. Lessons for CEOs from the consolidation of the medical device and diagnostic industries. International Journal of Medical Marketing 2000;1(2):148-60. |
|||
==Research into Market Insight== |
|||
• Rowland K, Smith BD. Achieving a Market Led Culture: A Case Study. International Journal of Medical Marketing 2001;1(3):215-23. |
|||
Smith's work into market insight seeks to unravel the process by which firms translate data into information, information into knowledge, knowledge into insight and insight into value. |
|||
• Smith BD. The Effectiveness of Marketing Strategy Making Processes: A Critical Literature Review and a Research Agenda. Journal of Targeting, Measurement and Analysis for Marketing 2003;2(3):273 |
|||
• Smith BD. An Empirical Investigation of Marketing Strategy Quality in Medical Markets. International Journal of Medical Marketing 2003;3(2):153-62. |
|||
• Smith BD. Success and Failure in Marketing Strategy Making: Results of an Empirical Study Across Medical Markets. International Journal of Medical Marketing 2003;3(4):287-315. |
|||
• Smith BD. Making marketing happen: How great medical companies make strategic marketing planning work for them. International Journal of Medical Marketing 2003 Dec;4(2):129-42. |
|||
• Smith BD, Wilson HN, Clark M. Creating and Using Customer Insight: 12 Rules of Best Practice. Journal of Medical Marketing 2006;6(2):135-9. |
|||
• Smith BD, Awopetu B. Mind Set and Market Segmentation in Pharmaceutical Industry: An Assessment of Practice in the UK. Journal of Pharmaceutical Marketing and Management 2007;17(3/4). |
|||
• Wilson H, Clark M, Smith B. Justifying CRM projects in a business-to-business context: The potential of the Benefits Dependency Network. Industrial Marketing Management 2007 Aug;36(6):770-83 |
|||
• Smith BD. Myth, reality and requirements in pharmaceutical Key Account Management. Journal of Medical Marketing 2009;9(2):89-95. |
|||
• Smith BD. An Exploratory Study of Key Opinion Leadership Management Trends amongst European Pharmaceutical Companies. Journal of Medical Marketing 2009;9(4). |
|||
• Smith BD. Maybe I Will, Maybe I Won't: What the Connected Perspectives of Motivation Theory and Organisational Commitment May Contribute to our Understanding of Strategy Implementation. Journal of Strategic Marketing 2009;17(6):469-81. |
|||
• Smith BD, Turf Wars: What the Intraorganisational Conflict Literature May Contribute to our Understanding of Marketing Strategy Implementation. Journal of Strategic Marketing 2011; 19(1): 25-42 |
|||
• Smith, BD, Excellence in Market Access Strategy: A Research Based Definition and Diagnostic Tool. Journal of Medical Marketing 2012, 12(4) 259-266 |
|||
• Smith, BD; Tarricone, R; Vella, V; The Role of Product Life Cycle in Medical Technology Innovation. Journal of Medical Marketing, 15 (1) January 2013 |
|||
• Smith, BD. Testing an Elusive Phenomenon: Developing and Testing a Multiple Perspective Model of Marketing Strategy Implementation. Journal of Strategic Marketing. 21 (5) August 2013 |
|||
• Smith, BD. Between Saying and Doing Lies the Ocean: An Empirical Exploration of the Gap between Strategic Marketing Plans and their Implementation in the Life Sciences Industry. Accepted for publication in Journal of Strategic Marketing, 2017 |
|||
This work was co-developed with Dr Paul Raspin [http://www.stratevolve.com/paul-raspin.htm] (PhD, Cranfield University). Smith and Raspin's combined work examines how executives scan the market environment to gather data, then organise the data into information and synthesise that information into market knowledge. |
|||
===Research contributions=== |
|||
Contributions made by Smith and Raspin to this field of research include the following, both described in their book, ''Creating Market Insight'': |
|||
* Identification of exactly what insight is and how it is distinct from knowledge. Smith and Raspin used concepts from Resource Based View of strategy. |
|||
* New thinking into the iterative process by which data is translated into value, a process captured in what has become known as the Smith Wheel. <!-- How to include an image of this? --> |
|||
==Research into strategy implementation== |
|||
In recent years, Smith has begun to explore the issue of strategy implementation. In academic presentations, he describes this as a 'messy' problem, poorly researched because it stretches across many different academic silos. He attempts to look at strategy implementation from two perspectives: |
|||
# The role of individual commitment and motivation, using the work of Locke, Vroom and Meyer and Allen. |
|||
# The role of intra-organisational conflict, which draws on earlier work on this subject by Pondy and Dutton and Walton, overlaying this with theories from social psychology such as Realistic Conflict Theory and Social Identity Theory. |
|||
This work has so far been published only in academic papers and internal Open University presentations. |
|||
==References== |
==References== |
||
Revision as of 11:09, 7 July 2017
Brian David Smith PhD, BSc (Hons), FCIM, is an academic researcher and author in the area of strategic management, with a particular interest in the evolution of business models and competitive strategies in the life science sector, especially pharmaceuticals and medical technology.In addition to his research and writing, he also advises a range of companies in this industry.
Early life and education
Brian David Smith was born in Hebburn in 1961. Smith's first degree was in Chemistry from Newcastle University (1983). He then spent 5 years working as a research chemist and a further 15 years in marketing management with large pharmaceutical and medical technology companies. He became a qualified marketer in 1989 and served as the first non-academic examiner for the Chartered Institute of Marketing. For almost 30 years, he was heavily involved in the CIM, especially as chair of its Levitt Group for senior and qualified marketers. In 2003, he gained his PhD from Cranfield School of Management. His thesis, supervised by Professor Malcolm McDonald, was entitled The Effectiveness of Strategy Making Processes in Medical Markets.
Academic career
He is an adjunct Professor at Bocconi University in Milan, Italy, where he teaches Strategy and Organisational Behaviour on the MIHMEP programme and does research in the CERGAS research centre. He is also a Visiting Professor at the University of Hertfordshire, where he supervises a group of PhD students focused on the evolution of the life sciences industry.
As an author, he has written more than 300 papers, articles and books. These include five major books.[1]. These include Darwin's Medicine and The Future of Pharma, which are perhaps his best known works. Smith was also the editor of the Journal of Medical Marketing, a peer-reviewed journal.[2]
As an advisor, he works mostly in the pharmaceutical, medical technology and related sectors, in which he has spent his management career. He has worked with most of the major companies and many smaller ones in this industry.
Research
Current research
Smith's current research focus is on the application of Darwinian Evolution to understand the evolution of business models in the life sciences industry. His work builds on his prior research streams concerning the effectiveness of strategy making in life science companies, how firms create market insight and the connection between strategy and commercial outcomes. His peer-reviewed research publications include:
• Smith BD. Lessons for CEOs from the consolidation of the medical device and diagnostic industries. International Journal of Medical Marketing 2000;1(2):148-60. • Rowland K, Smith BD. Achieving a Market Led Culture: A Case Study. International Journal of Medical Marketing 2001;1(3):215-23. • Smith BD. The Effectiveness of Marketing Strategy Making Processes: A Critical Literature Review and a Research Agenda. Journal of Targeting, Measurement and Analysis for Marketing 2003;2(3):273 • Smith BD. An Empirical Investigation of Marketing Strategy Quality in Medical Markets. International Journal of Medical Marketing 2003;3(2):153-62. • Smith BD. Success and Failure in Marketing Strategy Making: Results of an Empirical Study Across Medical Markets. International Journal of Medical Marketing 2003;3(4):287-315. • Smith BD. Making marketing happen: How great medical companies make strategic marketing planning work for them. International Journal of Medical Marketing 2003 Dec;4(2):129-42. • Smith BD, Wilson HN, Clark M. Creating and Using Customer Insight: 12 Rules of Best Practice. Journal of Medical Marketing 2006;6(2):135-9. • Smith BD, Awopetu B. Mind Set and Market Segmentation in Pharmaceutical Industry: An Assessment of Practice in the UK. Journal of Pharmaceutical Marketing and Management 2007;17(3/4). • Wilson H, Clark M, Smith B. Justifying CRM projects in a business-to-business context: The potential of the Benefits Dependency Network. Industrial Marketing Management 2007 Aug;36(6):770-83 • Smith BD. Myth, reality and requirements in pharmaceutical Key Account Management. Journal of Medical Marketing 2009;9(2):89-95. • Smith BD. An Exploratory Study of Key Opinion Leadership Management Trends amongst European Pharmaceutical Companies. Journal of Medical Marketing 2009;9(4). • Smith BD. Maybe I Will, Maybe I Won't: What the Connected Perspectives of Motivation Theory and Organisational Commitment May Contribute to our Understanding of Strategy Implementation. Journal of Strategic Marketing 2009;17(6):469-81. • Smith BD, Turf Wars: What the Intraorganisational Conflict Literature May Contribute to our Understanding of Marketing Strategy Implementation. Journal of Strategic Marketing 2011; 19(1): 25-42 • Smith, BD, Excellence in Market Access Strategy: A Research Based Definition and Diagnostic Tool. Journal of Medical Marketing 2012, 12(4) 259-266 • Smith, BD; Tarricone, R; Vella, V; The Role of Product Life Cycle in Medical Technology Innovation. Journal of Medical Marketing, 15 (1) January 2013 • Smith, BD. Testing an Elusive Phenomenon: Developing and Testing a Multiple Perspective Model of Marketing Strategy Implementation. Journal of Strategic Marketing. 21 (5) August 2013 • Smith, BD. Between Saying and Doing Lies the Ocean: An Empirical Exploration of the Gap between Strategic Marketing Plans and their Implementation in the Life Sciences Industry. Accepted for publication in Journal of Strategic Marketing, 2017
References
External links
| International | |
|---|---|
| National | |
| Other | |
